- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01412723
Ferrous Sulfate Versus Iron Amino Acid Chelate
EFICACIA DEL HIERRO AMINOQUELADO COMPARADO CON EL SULFATO FERROSO COMO COMPLEMENTO ALIMENTARIO EN PREESCOLARES CON DEFICIENCIA DE HIERRO.
Iron deficiency and depleted levels of iron are the most prevalent nutritional deficiency and the leading cause of anemia in the world; this can occur at any age, but preschool children are at particular risk of developing it. This condition may cause serious repercussions for life, being a public health threat of considerable importance worldwide.
Food fortification is considered the most effective solution to counter this situation, because it can help more people than other solutions. It is going to carry out a community trial to compare the efficacy of ferrous sulfate with respect to iron amino acid chelate as a dietary supplement in preschool children of Medellin with depleted levels of iron; in terms of increasing ferritin levels in blood and maintain hemoglobin levels. It is hypothesized that at the end of the study the effect of milk fortified with iron amino acid chelate won't be less than the effect of fortified with ferrous sulfate.
It is hoped that the results may contribute, albeit indirectly, to improve the health status of children with depleted levels of iron whom consume iron-fortified products.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Antioquia
-
Medellin, Antioquia, Colombia
- Universidad CES
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Children who
- Belong to institute FAN in Medellín
- Attend full time to institute FAN (eight hours)
- Have 2 to 5 years inclusive
- Submit depleted levels of iron (ferritin level equal to or less than 24 mg/L)
Exclusion Criteria:
Children who
- Submit anemia (hemoglobin level equal to or less than 11 g/dL)
- Have not stool analysis before intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Ferrous sulphate
Preschool children with depleted levels of iron enrolled in FAN Foundation of Medellin, which will be supplied with ferrous sulfate-fortified milk
|
Ferrous sulfate as dietary supplementation
|
|
Experimental: Iron Amino acid chelate
Preschool children with depleted levels of iron enrolled in FAN Foundation of Medellin , which will be supplied with iron amino acid chelate-fortified milk
|
Iron amino acid chelated as dietary supplementation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ferritin
Time Frame: Up to 8 weeks
|
The Ferritin level in blood will be measured at the beginning of the study as one of the most important inclusion criteria.
This also will be the base line of the study.
After that randomization will be carried out and after two months (time frame which ferrous sulfate or iron aminoacid chelate would increase ferritin level in blood) ferritin level will be measured again as the primary outcome measure.
|
Up to 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin
Time Frame: Up to 8 weeks
|
The Hemoglobin level in blood will be measured at the beginning of the study as one of the most important exclusion criteria.
After that randomization will be carried out and after two months (time frame which ferrous sulfate or iron aminoacid chelate would increase ferritin level in blood) hemoglobin level will be measured again as one of secundary outcome measure.
The hypothesis is that the hemoglobin level won't decrease
|
Up to 8 weeks
|
|
Infection
Time Frame: Daily. During 2 months of intervention
|
Daily written report of the caregiver during the intervention
|
Daily. During 2 months of intervention
|
|
Adverse reaction
Time Frame: Daily. During 2 months of intervention
|
The caregiver recorded daily if the child had an adverse reaction such as abdominal pain, nausea, vomiting, constipation, diarrhea, darkening of feces, and disgust for food.
|
Daily. During 2 months of intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ana M Herrera, PhD en Patología, CES University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SFHA-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron Deficiency
-
Pennington Biomedical Research CenterCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States
-
Tampere University HospitalTampere UniversityRecruitingIron Deficiency | Iron Deficiency Anaemia in Childbirth | Iron Status | Iron Deficiency in Pregnancy | Iron Deficiency Anemia in PregnancyFinland
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Children's Hospital Los AngelesNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingAnemia | Iron Deficiency Anemia | Anemia, Iron Deficiency | IDA - Iron Deficiency AnemiaUnited States
-
Antalya Training and Research HospitalCompletedIron Deficiency Anemia | Iron Deficiency Anemia TreatmentTurkey
-
Arrowhead Regional Medical CenterRecruitingIron Deficiency Anemia of PregnancyUnited States
-
CMH Multan Institute of Medical SciencesCompletedPregnancy | Iron Deficiency Anemia (IDA)Pakistan
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); Syracuse University; Liverpool... and other collaboratorsCompletedIron-deficiency | Iron-deficiency AnemiaGhana
-
Société des Produits Nestlé (SPN)CompletedIron-deficiency | Anemia | Iron Deficiency AnemiaPhilippines
-
Swiss Federal Institute of TechnologyUniversity of MalawiCompletedIron-deficiency | Iron Deficiency AnemiaMalawi, Switzerland
Clinical Trials on Ferrous sulfate as dietary supplementation
-
Shahida Islam Medical ComplexCompletedPostpartum AnaemiaPakistan
-
CES UniversityNutreva S.A.S.; Foundation Child Care - FANCompleted
-
University of Colorado, DenverNot yet recruitingHypoxia | Right Ventricular DysfunctionUnited States
-
Icahn School of Medicine at Mount SinaiCompletedIron Deficiency AnemiaUnited States
-
Solvotrin Innovations LtdActive, not recruitingIron-deficiency | Iron Deficiency Anemia | Heavy Menstrual Bleeding | Premenopause | Iron Adverse ReactionIreland
-
University of CalgaryMitacs; Natural Sciences and Engineering Research Council, CanadaRecruiting
-
King's College LondonCompletedIron Deficiency Anaemia Due to Dietary CausesUnited Kingdom
-
Swiss Federal Institute of TechnologyUniversity of Oxford; St. Luke's Medical CenterTerminatedIron-deficiencyPhilippines
-
National Cardiovascular Center Harapan Kita Hospital...CompletedHeart Failure, Systolic | Iron-deficiency Anemia
-
Hugo W. Moser Research Institute at Kennedy Krieger...Not yet recruitingADHD | Sleep ProblemsUnited States